Average Insider

Where insiders trade, we follow

Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ€“ Chief Financial Officer
Aug 18, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$9.54
Current$16.1244.7% above low, 55.3% below high
Purchase$9.882.3% above low, 97.7% below high
52W High$24.27
Shares
31,031
Price
$9.88
Total Value
$306,586.28

Nearby Earnings

No earnings within 2 weeks of this transaction.

Transaction Details

InsiderSullivan Christopher Ryan
TitleChief Financial Officer
Transaction DateAug 18, 2026
Transaction CodeM Exercise/Conversion
Acquired/DisposedAcquired
Security
Common Stock
Direct/IndirectDirect
Filing DateAug 19, 2026
Shares Purchased31,031
Price per Share$9.88
Total Value$306,586.28
Shares Owned After70,931
DerivativeNo
Accession Number0001810417-26-000019
DocumentView SEC Filing
Version: v26.7.3